Shu Wu

Shu(Simon) Wu has extensive experience in the biotech industry. Shu(Simon) joined GenScript in 2008 and held various roles, including Scientist, Manager of Antibody Engineering Department, Executive Manager of Discovery Biology Business Unit, and Operation Vice President of Discovery Biology Business Unit. In 2017, Shu Wu joined Qragen as the Vice President of Operations, where they played a key role in the research and development of next-generation therapeutic antibodies. Later in the same year, they joined Legend Biotech as the Vice President of Operations.

Shu (Simon) Wu completed their Bachelor's degree in Biology Science at Nanjing Agricultural University from 2001 to 2005. Shu(Simon) then pursued a Master's degree in Environmental Biology at the University of Chinese Academy of Sciences from 2005 to 2008.